News Focus
News Focus
Followers 96
Posts 615
Boards Moderated 0
Alias Born 08/24/2016

Re: AlchemicalVoyager13 post# 509586

Monday, 11/24/2025 10:02:48 AM

Monday, November 24, 2025 10:02:48 AM

Post# of 517311
My projections were based on ABCLEAR1 as the primary target population. It seems likely Anavex will be approved at re-eval with a narrower indication (ABCLEAR1). GLP-1 failure assists these market penetration forecasts.

For now, nothing has changed.

Curious what Missling will say tomorrow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News